Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001104659-24-025685 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | 2024-02-15 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir | F - Tax | $28.23 | -3,717 | 615.5K | -0.6% | -$104.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | F | D | 3,717 | $28.23 | 615,505 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 10,417 restricted stock units on February 15, 2024. |